Euroapi S.A. (EAPIF) Financials
EAPIF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 1.4 billion | 595.4 million |
| Dec. 31, 2025 | 1.5 billion | 606.4 million |
| June 30, 2025 | 1.7 billion | 575.7 million |
| Dec. 31, 2024 | 1.6 billion | 526.9 million |
EAPIF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -119.2 million | ? |
| Dec. 31, 2025 | 79.4 million | ? |
| June 30, 2025 | -22.9 million | ? |
| Dec. 31, 2024 | 5.2 million | -2.4 million |
EAPIF Net Income
No data available :(
EAPIF Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 59.3 million | - | 17.0 million |
| Dec. 31, 2025 | 133.5 million | - | 23.4 million |
| June 30, 2025 | 68.1 million | - | 21.1 million |
| Dec. 31, 2024 | 76.0 million | - | 19.3 million |
EAPIF Shares Outstanding
EAPIF Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 44.6 million | 14.4 million | 59.1 million | - |
| Dec. 31, 2025 | 47.8 million | 20.1 million | 69.7 million | 21.7 million |
| June 30, 2025 | 44.6 million | 12.0 million | 68.1 million | 20.0 million |
| Dec. 31, 2024 | 48.6 million | 12.4 million | 62.9 million | 19.7 million |
EAPIF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 406.3 million | 342.7 million |
| Dec. 31, 2025 | 511.8 million | 434.0 million |
| June 30, 2025 | 488.6 million | 398.3 million |
| Dec. 31, 2024 | 487.7 million | 441.4 million |
EAPIF
Price: $0.84
52 week price:
Earnings Per Share: -2.56 USD
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 80.7 million